Dubey D - Search Results

1

Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.

Menge T, Dubey D, Warnke C, Hartung HP, Stüve O. Menge T, et al. Among authors: dubey d. Expert Rev Neurother. 2016 Oct;16(10):1131-9. doi: 10.1080/14737175.2016.1227242. Epub 2016 Sep 1. Expert Rev Neurother. 2016. PMID: 27552111 Review.

2

Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations.

Dubey D, Sharma VD, Pass SE, Sawhney A, Stüve O. Dubey D, et al. Ther Adv Neurol Disord. 2014 May;7(3):177-87. doi: 10.1177/1756285614521889. Ther Adv Neurol Disord. 2014. PMID: 24790648 Free PMC article. Review.

3

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.

Dubey D, Kieseier BC, Hartung HP, Hemmer B, Miller-Little WA, Stuve O. Dubey D, et al. Expert Rev Clin Immunol. 2015 Jan;11(1):93-108. doi: 10.1586/1744666X.2015.992881. Epub 2014 Dec 15. Expert Rev Clin Immunol. 2015. PMID: 25495182 Review.

4

Spinal gout: A rare cause of paraplegia.

Dubey D, Steen E, Sawhney A, Stuve O. Dubey D, et al. Neurol India. 2015 Mar-Apr;63(2):284-5. doi: 10.4103/0028-3886.156318. Neurol India. 2015. PMID: 25948010 Free article. No abstract available.

5

Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.

Dubey D, Cano CA, Stuve O. Dubey D, et al. Neuropsychiatr Dis Treat. 2015 Sep 18;11:2405-14. doi: 10.2147/NDT.S90473. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26425095 Free PMC article. Review.

6

The spectrum of autoimmune encephalopathies.

Dubey D, Sawhney A, Greenberg B, Lowden A, Warnack W, Khemani P, Stuve O, Vernino S. Dubey D, et al. J Neuroimmunol. 2015 Oct 15;287:93-7. doi: 10.1016/j.jneuroim.2015.08.014. Epub 2015 Aug 28. J Neuroimmunol. 2015. PMID: 26439968

7

Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.

Dubey D, Cano CA, Stüve O. Dubey D, et al. Curr Opin Neurol. 2016 Jun;29(3):278-85. doi: 10.1097/WCO.0000000000000321. Curr Opin Neurol. 2016. PMID: 27027553 Review.

8

Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.

Dubey D, Cano CA, Stüve O. Dubey D, et al. Curr Opin Neurol. 2016 Jun;29(3):272-7. doi: 10.1097/WCO.0000000000000320. Curr Opin Neurol. 2016. PMID: 27035896 Review.

9

Managing Disability in Progressive Multiple Sclerosis.

Dubey D, Sguigna P, Stüve O. Dubey D, et al. Curr Treat Options Neurol. 2016 Jun;18(6):27. doi: 10.1007/s11940-016-0412-7. Curr Treat Options Neurol. 2016. PMID: 27089873 Review.

10

Diagnostic and therapeutic strategies for management of autoimmune encephalopathies.

Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S. Dubey D, et al. Expert Rev Neurother. 2016 Aug;16(8):937-49. doi: 10.1080/14737175.2016.1189328. Epub 2016 May 30. Expert Rev Neurother. 2016. PMID: 27171736 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters